The Role of TRPC6 in the Neuroprotection of Calycosin Against Cerebral Ischemic Injury

[1]  C. Duarte,et al.  Calpains and neuronal damage in the ischemic brain: The swiss knife in synaptic injury , 2016, Progress in Neurobiology.

[2]  Siwei Zhang,et al.  The calpain system is associated with survival of breast cancer patients with large but operable inflammatory and non-inflammatory tumours treated with neoadjuvant chemotherapy , 2016, Oncotarget.

[3]  W. Guo,et al.  Expression of TRPC6 and BDNF in Cortical Lesions From Patients With Focal Cortical Dysplasia , 2016, Journal of neuropathology and experimental neurology.

[4]  Xiang Wang,et al.  Calycosin ameliorates diabetes-induced cognitive impairments in rats by reducing oxidative stress via the PI3K/Akt/GSK-3β signaling pathway. , 2016, Biochemical and biophysical research communications.

[5]  W. Xu,et al.  Bryonolic Acid, a Triterpenoid, Protect Against N-methyl-d-Aspartate-Induced Neurotoxicity in PC12 Cells , 2016, Molecules.

[6]  M. Kessentini,et al.  A Systematic Literature Review , 2016 .

[7]  Xuemei Zhang,et al.  Up-Regulatory Effects of Curcumin on Large Conductance Ca2+-Activated K+ Channels , 2015, PloS one.

[8]  Jiong Shi,et al.  Pertussis toxin reduces calcium influx to protect ischemic stroke in a middle cerebral artery occlusion model , 2015, Journal of neurochemistry.

[9]  Wan‐chun Sun,et al.  Calycosin Suppresses RANKL-Mediated Osteoclastogenesis through Inhibition of MAPKs and NF-κB , 2015, International journal of molecular sciences.

[10]  M. Duan,et al.  Hydrogen sulphide and mild hypothermia activate the CREB signaling pathway and prevent ischemia-reperfusion injury , 2015, BMC Anesthesiology.

[11]  L. Jian,et al.  Protective effect of calycosin-7-O-β-D-glucopyranoside against oxidative stress of BRL-3A cells induced by thioacetamide , 2015, Pharmacognosy magazine.

[12]  L. Edvinsson,et al.  Cerebrovascular endothelin‐1 hyper‐reactivity is associated with transient receptor potential canonical channels 1 and 6 activation and delayed cerebral hypoperfusion after forebrain ischaemia in rats , 2015, Acta physiologica.

[13]  M. Nilsson,et al.  Combined Ampakine and BDNF Treatments Enhance Poststroke Functional Recovery in Aged Mice via AKT-CREB Signaling , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[14]  M. Xiao,et al.  Minocycline upregulates cyclic AMP response element binding protein and brain-derived neurotrophic factor in the hippocampus of cerebral ischemia rats and improves behavioral deficits , 2015, Neuropsychiatric disease and treatment.

[15]  A. Wen,et al.  Neuroprotective effect and underlying mechanism of sodium danshensu [3-(3,4-dihydroxyphenyl) lactic acid from Radix and Rhizoma Salviae miltiorrhizae = Danshen] against cerebral ischemia and reperfusion injury in rats. , 2015, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[16]  Li Lin,et al.  Calycosin induces apoptosis in human ovarian cancer SKOV3 cells by activating caspases and Bcl-2 family proteins , 2015, Tumor Biology.

[17]  A. Wen,et al.  Neuroprotection by Acetyl-11-Keto-β-Boswellic Acid, in Ischemic Brain Injury Involves the Nrf2/HO-1 defense Pathway , 2014, Scientific Reports.

[18]  Xiang Cheng,et al.  IL-17A contributes to brain ischemia reperfusion injury through calpain-TRPC6 pathway in mice , 2014, Neuroscience.

[19]  Yu Ye,et al.  Antineoplastic effect of calycosin on osteosarcoma through inducing apoptosis showing in vitro and in vivo investigations. , 2014, Experimental and molecular pathology.

[20]  H. Neuhof,et al.  Calpain system and its involvement in myocardial ischemia and reperfusion injury. , 2014, World journal of cardiology.

[21]  Ulrich Dirnagl,et al.  Stroke induced Sarcopenia: muscle wasting and disability after stroke. , 2013, International journal of cardiology.

[22]  Cheng-ye Yao,et al.  Neuroprotectin D1 attenuates brain damage induced by transient middle cerebral artery occlusion in rats through TRPC6/CREB pathways. , 2013, Molecular medicine reports.

[23]  Xiaoming Zhang,et al.  Endoplasmic Reticulum Stress-Mediated Hippocampal Neuron Apoptosis Involved in Diabetic Cognitive Impairment , 2013, BioMed research international.

[24]  L. Pettigrew,et al.  Calpain cleaves methionine aminopeptidase-2 in a rat model of ischemia/reperfusion , 2013, Brain Research.

[25]  Jie Wang,et al.  Hyperforin Attenuates Brain Damage Induced by Transient Middle Cerebral Artery Occlusion (MCAO) in Rats via Inhibition of TRPC6 Channels Degradation , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[26]  A. Wen,et al.  Neuroprotective effect of calycosin on cerebral ischemia and reperfusion injury in rats. , 2012, Journal of ethnopharmacology.

[27]  Z. Qin,et al.  Inhibition of NF-κB activation is associated with anti-inflammatory and anti-apoptotic effects of Ginkgolide B in a mouse model of cerebral ischemia/reperfusion injury. , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[28]  R. Campbell,et al.  Structure-function relationships in calpains. , 2012, The Biochemical journal.

[29]  U. Dirnagl.  Pathobiology of injury after stroke: the neurovascular unit and beyond , 2012, Annals of the New York Academy of Sciences.

[30]  S. Peng,et al.  The protective effects and potential mechanism of Calpain inhibitor Calpeptin against focal cerebral ischemia–reperfusion injury in rats , 2011, Molecular Biology Reports.

[31]  Wanlu Du,et al.  Inhibition of TRPC6 degradation suppresses ischemic brain damage in rats. , 2010, The Journal of clinical investigation.

[32]  B. Demaerschalk,et al.  US cost burden of ischemic stroke: a systematic literature review. , 2010, The American journal of managed care.

[33]  Mingxia Sun,et al.  Neuroprotective actions of aminoguanidine involve reduced the activation of calpain and caspase-3 in a rat model of stroke , 2010, Neurochemistry International.

[34]  Robert H Christenson,et al.  Stroke biomarkers: progress and challenges for diagnosis, prognosis, differentiation, and treatment. , 2010, Clinical chemistry.

[35]  Chang-an Yu,et al.  Adiponectin protects against cerebral ischemia–reperfusion injury through anti-inflammatory action , 2009, Brain Research.

[36]  D. Clapham,et al.  Essential Role for TRPC5 in Amygdala Function and Fear-Related Behavior , 2009, Cell.

[37]  W. Sossin,et al.  Something old, something new: BDNF-induced neuron survival requires TRPC channel function , 2007, Nature Neuroscience.

[38]  Jian Zhou,et al.  TRPC channels promote cerebellar granule neuron survival , 2007, Nature Neuroscience.

[39]  P. Nicotera,et al.  Ca2+ Signals and Neuronal Death in Brain Ischemia , 2007, Stroke.

[40]  S. Ray.  Currently evaluated calpain and caspase inhibitors for neuroprotection in experimental brain ischemia. , 2006, Current medicinal chemistry.

[41]  Yu-ying Zhao,et al.  Calcium channel blocking activity of calycosin, a major active component of Astragali Radix, on rat aorta , 2006, Acta Pharmacologica Sinica.

[42]  R. Habas,et al.  TRPM7 Regulates Cell Adhesion by Controlling the Calcium-dependent Protease Calpain* , 2006, Journal of Biological Chemistry.

[43]  Zhen Yan,et al.  Regulation of N-Methyl-D-aspartate Receptors by Calpain in Cortical Neurons* , 2005, Journal of Biological Chemistry.

[44]  Ning Li,et al.  Essential role of TRPC channels in the guidance of nerve growth cones by brain-derived neurotrophic factor , 2005, Nature.

[45]  T. Pozzan,et al.  Reduction of Ca2+ stores and capacitative Ca2+ entry is associated with the familial Alzheimer's disease presenilin-2 T122R mutation and anticipates the onset of dementia , 2005, Neurobiology of Disease.

[46]  I. Fantozzi,et al.  Enhanced expression of transient receptor potential channels in idiopathic pulmonary arterial hypertension. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[47]  Ying Zhang,et al.  [Time-course of mu-calpain activation, c-Fos, c-Jun, HSP70 and HSP27 expression in hypoxic-ischemic neonatal rat brain]. , 2004, Zhonghua er ke za zhi = Chinese journal of pediatrics.

[48]  Wade S. Smith.  Pathophysiology of focal cerebral ischemia: a therapeutic perspective. , 2004, Journal of vascular and interventional radiology : JVIR.

[49]  D. Clapham,et al.  TRPC5 is a regulator of hippocampal neurite length and growth cone morphology , 2003, Nature Neuroscience.

[50]  D. E. Goll,et al.  The calpain system. , 2003, Physiological reviews.

[51]  L. Xiong,et al.  Preconditioning with Isoflurane Produces Dose-Dependent Neuroprotection via Activation of Adenosine Triphosphate-Regulated Potassium Channels After Focal Cerebral Ischemia in Rats , 2003, Anesthesia and analgesia.

[52]  A. Enjalbert,et al.  Proteasome Implication in Phorbol Ester- and GnRH-Induced Selective Down-Regulation of PKC (α, ε, ζ) in αT3-1 and LβT2 Gonadotrope Cell Lines. , 2002, Endocrinology.

[53]  A. Enjalbert,et al.  Proteasome implication in phorbol ester- and GnRH-induced selective down-regulation of PKC (alpha, epsilon, zeta) in alpha T(3)-1 and L beta T(2) gonadotrope cell lines. , 2002, Endocrinology.

[54]  S. Nakashima,et al.  Crucial role of calpain in hypoxic PC12 cell death: Calpain, but not caspases, mediates degradation of cytoskeletal proteins and protein kinase C-α and-δ , 2001 .

[55]  R. Neumar,et al.  Calpain Activity in the Rat Brain after Transient Forebrain Ischemia , 2001, Experimental Neurology.

[56]  S. Nakashima,et al.  Crucial role of calpain in hypoxic PC12 cell death: calpain, but not caspases, mediates degradation of cytoskeletal proteins and protein kinase C-alpha and -delta. , 2001, Neurological research.

[57]  G. Demartino,et al.  Calcium-activated neutral protease (calpain) system: structure, function, and regulation. , 1991, Physiological reviews.

[58]  P. Weinstein,et al.  Reversible middle cerebral artery occlusion without craniectomy in rats. , 1989, Stroke.

[59]  C. Williamson,et al.  Therapeutic perspective. , 1951, California medicine.